Gunther Birznieks

SVP, Business Development, Vanda Pharmaceuticals Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 2, 2026Sold 42,431 shares at $8.27 of Vanda Pharmaceuticals Inc.²
Feb 18, 2026Granted 125,000 shares of Vanda Pharmaceuticals Inc.³
Mar 1, 2025Shares withheld for tax 26,941 shares at $4.76 of Vanda Pharmaceuticals Inc.⁴
Feb 18, 2025Granted 125,000 shares of Vanda Pharmaceuticals Inc.⁵
Mar 5, 2024Sold 8,684 shares at $4.13 of Vanda Pharmaceuticals Inc.⁶
Mar 4, 2024Sold 8,727 shares at $4.30 of Vanda Pharmaceuticals Inc.⁶
Feb 16, 2024Granted 125,000 shares of Vanda Pharmaceuticals Inc.⁷
Mar 3, 2023Sold 8,268 shares at $6.26 of Vanda Pharmaceuticals Inc.⁸
Mar 2, 2023Sold 8,509 shares at $6.20 of Vanda Pharmaceuticals Inc.⁸
Feb 16, 2023Granted 32,700 shares of Vanda Pharmaceuticals Inc.⁹
Aug 26, 2022Exercised options 1,250 shares at $3.12 of Vanda Pharmaceuticals Inc.¹⁰
Mar 2, 2022Sold 11,517 shares at $11.27 of Vanda Pharmaceuticals Inc.¹¹
Mar 1, 2022Sold 4,084 shares at $11.19 of Vanda Pharmaceuticals Inc.¹¹
Feb 28, 2022Granted 32,700 shares of Vanda Pharmaceuticals Inc.¹¹

The numbers on this page point here. Each one links to the record it came from.